Drug information provided by: Merative, Micromedex®
Caplacizumab-yhdp injection is used in combination with plasma exchange and immunosuppressive therapy (medicines to weaken the immune system) to treat acquired thrombotic thrombocytopenic purpura (aTTP).
This medicine is available only with your doctor's prescription.
Portions of this document last updated: Feb. 01, 2023
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
A generous benefactor has pledged $1 million and challenged us to raise an additional $250,000. Help us reach our goal!